Statistical Analysis and Biometric Programming

Shrikant Bangdiwala

Director, Statistics; Senior Scientist

Shrikant Bangdiwala, PhD, has extensive experience in the design, conduct and analysis of multi-center observational and experimental studies, having worked on clinical and community-based randomized controlled trials in congestive heart failure, cardiovascular risk factors, functional bowel disease, and obesity prevention. His statistical research interests include non-parametric methods, methodology for clinical trials, reliability and validity of diagnostic tests, and graphical methods for descriptive analyses.

A Professor in McMaster University’s Department of Health Research Methods, Evidence and Impact, he is a former Fulbright senior specialist in global public health, and holds faculty positions in universities in Chile, South Africa and India.

He is a member of the USA NIH National Institute of Allergy and Infectious Diseases (NIAID) “COVID-19 Preventive mAb Data and Safety Monitoring Board” (DSMB) that will be reviewing and monitoring the US government-supported clinical trials of candidate preventive monoclonal Antibodies for SARS-CoV-2 and COVID-19. He also chairs the Multinational DSMB for the division of AIDS at NIH, and is a member of the Gastrointestinal Drugs Advisory Committee of the FDA.

Leanne Dyal

Manager, Statistical Operations

Leanne Dyal is responsible for leading the development of data quality standards and processes across PHRI in accordance with industry standards. She was previously Manager, Data Management, and before that, Statistical Analyst with PHRI for several years, giving her a wealth of experience in, and knowledge of, study design, conduct, databases and data management.

She received her Bachelors of Science degree in Mathematics and Statistics, and Masters of Science Degree in Statistics, from McMaster University.